192 related articles for article (PubMed ID: 32643116)
1. Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia.
Szekerczés T; Galamb Á; Varga N; Benczik M; Kocsis A; Schlachter K; Kiss A; Ács N; Schaff Z; Jeney C; Lendvai G; Sobel G
Pathol Oncol Res; 2020 Oct; 26(4):2633-2640. PubMed ID: 32643116
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
3. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
4. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
[TBL] [Abstract][Full Text] [Related]
5. Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes.
Lee CH; Peng CY; Li RN; Chen YC; Tsai HT; Hung YH; Chan TF; Huang HL; Lai TC; Wu MT
Int J Cancer; 2015 Jan; 136(2):340-9. PubMed ID: 24841989
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expressions in HPV-induced cervical dysplasia and cancer.
Gocze K; Gombos K; Kovacs K; Juhasz K; Gocze P; Kiss I
Anticancer Res; 2015 Jan; 35(1):523-30. PubMed ID: 25550598
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
8. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
10. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
Tian R; Cui Z; He D; Tian X; Gao Q; Ma X; Yang JR; Wu J; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Zhong H; Fan W; Chen Y; Jin Z; Cao C; Yu M; Xie W; Huang Z; Bao Y; Xie H; Yao S; Hu Z
Carcinogenesis; 2019 Oct; 40(10):1220-1228. PubMed ID: 31102403
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
Kann H; Hortlund M; Eklund C; Dillner J; Faust H
Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
[TBL] [Abstract][Full Text] [Related]
14. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
15. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
[TBL] [Abstract][Full Text] [Related]
16. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
17. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
18. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
[TBL] [Abstract][Full Text] [Related]
19. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables.
Kruse AJ; Baak JP; Janssen EA; Bol MG; Kjellevold KH; Fianne B; Lovslett K; Bergh J
J Pathol; 2003 Apr; 199(4):462-70. PubMed ID: 12635137
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia.
Li Y; Liu J; Yuan C; Cui B; Zou X; Qiao Y
J Int Med Res; 2010; 38(5):1730-6. PubMed ID: 21309487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
